2003
DOI: 10.1016/s0304-4165(03)00137-5
|View full text |Cite
|
Sign up to set email alerts
|

Reduction of CMP-N-acetylneuraminic acid hydroxylase activity in engineered Chinese hamster ovary cells using an antisense-RNA strategy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
26
0

Year Published

2006
2006
2019
2019

Publication Types

Select...
3
2
2

Relationship

0
7

Authors

Journals

citations
Cited by 43 publications
(26 citation statements)
references
References 44 publications
0
26
0
Order By: Relevance
“…In contrast, there are very few literature reports describing the impact of culture conditions on glycoprotein Neu5Gc levels. Neu5Gc levels have been modulated using antisense-RNA techniques (Chenu et al, 2003), and there are reports of Neu5Gc being affected by environmental conditions such as high pCO 2 (Kimura and Miller, 1997), manipulation of nucleotide-sugar levels by feeding N-acetylmannosamine (Baker et al 2001), and by HEPES buffer and high pH (Muthing et al, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…In contrast, there are very few literature reports describing the impact of culture conditions on glycoprotein Neu5Gc levels. Neu5Gc levels have been modulated using antisense-RNA techniques (Chenu et al, 2003), and there are reports of Neu5Gc being affected by environmental conditions such as high pCO 2 (Kimura and Miller, 1997), manipulation of nucleotide-sugar levels by feeding N-acetylmannosamine (Baker et al 2001), and by HEPES buffer and high pH (Muthing et al, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…The glycoform distribution and the shifting pattern of microheterogeneity on glycoproteins has been reported to be affected by cell culture conditions (Andersen et al, 2000;Chee Furng Wong et al, 2005;Cruz et al, 2000;Gawlitzek et al, 1995;Nyberg et al, 1999;Yang and Butler, 2000). In the efforts to control glycoform diversity, attempts have been made to engineer enzymes involved in the protein N-glycosylation pathway (Chenu et al, 2003;Davies et al, 2001;Lee et al, 1989;Mori et al, 2004;Potvin et al, 1990;Sburlati et al, 1998;Weikert et al, 1999), and modify the media composition (Baker et al, 2001;Gu and Wang, 1998).…”
Section: Introductionmentioning
confidence: 99%
“…In most animal cells, and in particular rodent cells including CHO, the synthesis of sialic acid sugar nucleotides proceeds to N-glycolyl-neuraminic acid (Neu5Gc) because these cells typically possess CMP-N-acetylneuraminic acid hydroxylase (CMP-Neu5Ac hydroxylase) activity [121]. However, human cells lack this enzyme and therefore glycostructures containing terminal Neu5Gc-sialic acid can be considered a foreign epitope to the human immune system.…”
Section: Glycoengineering Methods Targeting the Sugar Nucleotide Metamentioning
confidence: 99%
“…Therefore, the absence of Neu5Gc-sialic acid is an important quality attribute of biotherapeutics. In order to mitigate this potential problem Chenu et al have engineered CHO lines to achieve a downregulated CMP-Neu5Ac hydroxylase activity [121].…”
Section: Glycoengineering Methods Targeting the Sugar Nucleotide Metamentioning
confidence: 99%